COVAX announces new agreement, plans for first deliveries

COVAX announces new agreement, plans for first deliveries
COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements. Additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021, via existing agreements with the Serum Institute of India (SII) and AstraZeneca. COVAX is therefore on track to deliver at least...

Comments

Popular posts from this blog

History of Escape Rooms

ABB Formula E Race At Home Challenge Round 6: Turvey back in top ten, Ma fought his way to the front

HSBC FUELS FILLING STATION REDEVELOPMENT IN PRESTON